Feasibility and safety of whole lung irradiation in the treatment of canine appendicular osteosarcoma.


Journal

Veterinary and comparative oncology
ISSN: 1476-5829
Titre abrégé: Vet Comp Oncol
Pays: England
ID NLM: 101185242

Informations de publication

Date de publication:
Mar 2022
Historique:
revised: 19 04 2021
received: 21 01 2021
accepted: 20 04 2021
pubmed: 24 4 2021
medline: 1 4 2022
entrez: 23 4 2021
Statut: ppublish

Résumé

Whole lung irradiation (WLI) has been used successfully in humans as an adjuvant treatment for osteosarcoma. The aim of this study is to describe the feasibility and safety of WLI in dogs with appendicular osteosarcoma. Twelve client-owned dogs with appendicular osteosarcoma that had successfully completed amputation and four doses of carboplatin without evidence of gross metastasis were enrolled in this prospective clinical trial. Ten once-daily fractions of 1.75 Gy were administered to the planning target volume encompassing the lungs. Overall, WLI was well tolerated in these patients. No dogs developed symptoms of pneumonitis or pulmonary fibrosis. Haematopoietic toxicity evaluated during radiation therapy was found to be mild. The median disease free interval for WLI treated dogs was not significantly different than the median DFI for a group of historic control dogs (376 days for WLI treated dogs versus 304.5 days for control dogs; p = 0.5461). Although no significant improvement in outcome was observed with this study, WLI appears to be safe in dogs and warrants further investigation to characterize the efficacy and toxicity.

Identifiants

pubmed: 33891368
doi: 10.1111/vco.12702
pmc: PMC9290556
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-28

Subventions

Organisme : American College of Veterinary Internal Medicine
ID : 535767
Organisme : Katherine and Rebecca Rochelle Chair in Oncology
Organisme : Texas A&M GINN Grant

Informations de copyright

© 2021 The Authors. Veterinary and Comparative Oncology published by John Wiley & Sons Ltd.

Références

Curr Med Chem. 2009;16(2):130-43
pubmed: 19149566
Front Oncol. 2019 Sep 06;9:877
pubmed: 31555602
J Vet Intern Med. 2014 Mar-Apr;28(2):554-63
pubmed: 24512451
Vet Res Commun. 2015 Mar;39(1):61-7
pubmed: 25422073
Anticancer Res. 2018 Sep;38(9):4977-4985
pubmed: 30194141
J Am Vet Med Assoc. 1995 May 15;206(10):1555-60
pubmed: 7775232
J Vet Intern Med. 2003 Mar-Apr;17(2):199-205
pubmed: 12683621
J Vet Intern Med. 2007 Jul-Aug;21(4):783-90
pubmed: 17708400
J Clin Oncol. 1992 Mar;10(3):459-63
pubmed: 1740684
Radiat Res. 1997 Feb;147(2):257-62
pubmed: 9008218
Vet Comp Oncol. 2022 Mar;20(1):20-28
pubmed: 33891368
J Am Anim Hosp Assoc. 2016 May-Jun;52(3):149-56
pubmed: 27008320
Pediatr Hematol Oncol. 1991 Apr-Jun;8(2):187-92
pubmed: 1863544
J Vet Intern Med. 2004 Jul-Aug;18(4):540-4
pubmed: 15320595
Med Phys. 2006 Oct;33(10):3874-900
pubmed: 17089851
Radiology. 1969 Nov;93(5):1173-9
pubmed: 4310815
Vet Comp Oncol. 2018 Mar;16(1):E23-E29
pubmed: 28621057
Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):463-9
pubmed: 14751516
Int J Radiat Oncol Biol Phys. 1986 Jun;12(6):907-10
pubmed: 3522504
J Am Anim Hosp Assoc. 2009 Jan-Feb;45(1):33-8
pubmed: 19122062
Int J Radiat Biol. 2000 Apr;76(4):463-8
pubmed: 10815625
J Am Vet Med Assoc. 1993 Jan 15;202(2):304-6
pubmed: 8428842
Recent Results Cancer Res. 1982;80:108-14
pubmed: 7036273
Cancer Treat Rep. 1980 Apr-May;64(4-5):701-03
pubmed: 6933006
J Am Vet Med Assoc. 2011 Jan 15;238(2):195-206
pubmed: 21235373
Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22
pubmed: 2032882
Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1069-1075
pubmed: 25035210
Vet Comp Oncol. 2016 Dec;14(4):417-446
pubmed: 28530307
Ann Radiol (Paris). 1973;16(5):385-92
pubmed: 4725815
Eur J Cancer. 1978 May;14(5):461-71
pubmed: 417923
BMC Bioinformatics. 2016 Feb 19;17:93
pubmed: 26892349
J Vet Intern Med. 1996 Mar-Apr;10(2):76-81
pubmed: 8683484
Ann Oncol. 2002 Jan;13(1):23-30
pubmed: 11863105
Eur J Cancer. 1973 Oct;9(10):747-52
pubmed: 4529731
Cancer. 1976 Aug;38(2):939-42
pubmed: 824047
Cancer. 1988 Mar 1;61(5):1024-31
pubmed: 3276390
Vet Radiol Ultrasound. 2001 Sep-Oct;42(5):475-6
pubmed: 11678573
Vet Comp Oncol. 2014 Dec;12(4):249-57
pubmed: 22985083
Clin Orthop Relat Res. 1997 Dec;(345):206-14
pubmed: 9418642

Auteurs

Amanda Brehm (A)

Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, USA.

Heather Wilson-Robles (H)

Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, USA.

Tasha Miller (T)

Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, USA.

Jill Jarvis (J)

Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, USA.

Michael Deveau (M)

Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH